Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_assertion type Assertion NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_head.
- NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_assertion description "[Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_provenance.
- NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_assertion evidence source_evidence_literature NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_provenance.
- NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_assertion SIO_000772 21422473 NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_provenance.
- NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_assertion wasDerivedFrom befree-2016 NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_provenance.
- NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_assertion wasGeneratedBy ECO_0000203 NP881036.RAF6lsXcvFPUvMp37HTAx-VeFGe9jDN1_zn4tBLaOU4hk130_provenance.